2-(Piperidin-1-yl)-7-(2,3,4-trimethoxyphenyl)-6,7-dihydrothiazolo[4,5-b]pyridin-5(4H)-one

Catalog No. :: ACXLOG282
CAS No. :: 1190286-28-2
Molecular Formula :: C20H25N3O4S
Molecular Weight :: 403.50

IUPAC Name:2-(piperidin-1-yl)-7-(2,3,4-trimethoxyphenyl)-6,7-dihydrothiazolo[4,5-b]pyridin-5(4H)-one

2-(Piperidin-1-yl)-7-(2,3,4-trimethoxyphenyl)-6,7-dihydrothiazolo[4,5-b]pyridin-5(4H)-one structure diagram

1mg95%$2409.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

0 Reviews:View Reviews

Product Information

Product Name	2-(Piperidin-1-yl)-7-(2,3,4-trimethoxyphenyl)-6,7-dihydrothiazolo[4,5-b]pyridin-5(4H)-one
IUPAC Name	2-(piperidin-1-yl)-7-(2,3,4-trimethoxyphenyl)-6,7-dihydrothiazolo[4,5-b]pyridin-5(4H)-one
Molecular Formula	C20H25N3O4S
Molecular Weight	403.50
SMILES	COC1=C(OC)C(OC)=C(C2CC(NC3=C2SC(N4CCCCC4)=N3)=O)C=C1
InChI Key	QLIWXIAQWGJNTF-UHFFFAOYSA-N
Synonym	2-(piperidin-1-yl)-7-(2,3,4-trimethoxyphenyl)-6,7-dihydro[1,3]thiazolo[4,5-b]pyridin-5-ol;Thiazolo[4,5-b]pyridin-5(4H)-one, 6,7-dihydro-2-(1-piperidinyl)-7-(2,3,4-trimethoxyphenyl)-
CAS No.	1190286-28-2

Synthetic Route by SureRoute

--
--
ACXLOG2821190286-28-2

Inquiry

--
--
ACXLOG2821190286-28-2

Inquiry

Recently Added

2-(Piperidin-1-yl)-7-(2,3,4-trimethoxyphenyl)-6,7-dihydrothiazolo[4,5-b]pyridin-5(4H)-one

Product Information

Synthetic Route by SureRoute

1. ACXLOG282 Molecular Building Block Synthetic Route

2. ACXLOG282 Molecular Building Block Synthetic Route

Comments (0)

2-(Piperidin-1-yl)-7-(2,3,4-trimethoxyphenyl)-6,7-dihydrothiazolo[4,5-b]pyridin-5(4H)-one

Product Information

Synthetic Route by SureRoute

7-(2,4-Dimethoxyphenyl)-2-morpholino-6,7-dihydrothiazolo[4,5-b]pyridin-5(4H)-one

{[(1S,2S)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amido}(p-cymene)(pyridine)ruthenium(II)

{[(1R,2R)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amido}(p-cymene)(pyridine)ruthenium(II)

ACDNEY033

Comments (0)